Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 10/20 | 0.69 |
| ▸ | CNR2 | P34972 | 10/20 | 0.58 |
| ▸ | POLB | P06746 | 1/20 | 0.58 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.58 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8793064 | 0.97 | CNR1 (0.68) | CNR1CNR2POLBL3MBTL1CREBBP | |
| SCHEMBL8792799 | 0.93 | CREBBP (0.65) | CNR1CNR2POLBL3MBTL1CREBBP | |
| SCHEMBL9334349 | 0.89 | CNR1 (0.68) | CNR1CNR2POLBL3MBTL1CREBBP | |
| SCHEMBL8793547 | 0.86 | CNR1 (0.73) | CNR1CNR2POLBL3MBTL1CREBBP | |
| SCHEMBL27304797 | 0.86 | CNR1 (0.70) | CNR1CNR2POLBL3MBTL1CREBBP | |
| SCHEMBL8792304 | 0.85 | CNR1 (0.65) | CNR1CNR2POLBL3MBTL1CREBBP | |
| SCHEMBL9335660 | 0.84 | CNR1 (0.67) | CNR1CNR2POLBL3MBTL1CREBBP | |
| SCHEMBL8792515 | 0.84 | CNR1 (0.67) | CNR1CNR2POLBL3MBTL1CREBBP | |
| SCHEMBL8792140 | 0.83 | CNR1 (0.66) | CNR1CNR2POLBL3MBTL1CREBBP | |
| SCHEMBL7934794 | 0.83 | CNR1 (0.63) | CNR1CNR2POLBL3MBTL1CREBBP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0458207-B1 | Indole derivatives | FUJISAWA PHARMACEUTICAL CO (JP) | 1997-03-26 | — | — | EP | disclosed |
| CN-1030701-C | Indole derivatives and process for production thereof | FUJISAWA PHARMACEUTICAL CO (JP) | 1996-01-17 | — | — | CN | disclosed |
| US-5312829-A | Testosterone 5alpha-reductase inhibitors | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1994-05-17 | — | — | US | disclosed |
| US-5212320-A | Enzyme inhibitors | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1993-05-18 | — | — | US | disclosed |
| EP-0458207-A2 | Indole derivatives | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1991-11-27 | — | — | EP | disclosed |